VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1792973
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210414; Test Name: Body temperature; Result Unstructured Data: Test Result:101.2; Comments: Temp of 101.2

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Extreme fatigue; Temp of 101.2; Chills; Severe headache/ headache secondday after; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 13:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and nature's bounty immune 24h (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 24Mar2021 at 13:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 01:00, the patient experienced temperature of 101.2, chills and severe headache from "1am to 3pm" after shot, extreme fatigue and headache second day after. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 14Apr2021 patient checked her body temperature and it was 101.2 (unspecified units). Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events temperature of 101.2, chills, severe headache and extreme fatigue was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN

Current Illness:

ID: 1792974
Sex: F
Age:
State: NJ

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Early periods; Late periods; Irregular cycles; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021(at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, asthma and allergy to topical drugs. The patient previously received diphenhydramine; paracetamol; phenylpropanolamine hydrochloride (BENADRYL) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) from an unknown date, for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the arm left on 11Feb2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation ( also reported that the patient was menstruating at time of 1st dose). The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Mar2021, the patient experienced next menstruation was a week early, 2 hours after second dose. On an unknown date in 2021, the patient experienced the following menstrual cycle which was 4 days late, then menstruating again 15 days into her menstruation cycle. The patient had not been in any other medication, no stress, no illness, and never had irregular cycles. This was completely new since the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events early periods, late periods and irregular cycles was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1792975
Sex: F
Age:
State: FL

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210413; Test Name: SARS-CoV-2 test; Test Result: Negative ; Comments: Test Type: Nasal Swab

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Severe body aches; Muscle and bones pain; Muscle and bones pain; Fever; Chills; Dizziness; Weakness; Nausea; Strong headache; Painful and swollen lymph node on the arm i got the vaccine.; Painful and swollen lymph node on the arm i got the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 15Apr2021 at 18:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included venlafaxine (MANUFACTURER UNKNOWN) and lamotrigine (MANUFACTURER UNKNOWN), both for unknown indications, from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 24Mar2021 at 17:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 13Apr2021, the patient underwent lab tests and procedures which included SARS-CoV-2 test (Test type: nasal swab) and the result was negative. On 15Apr2021 at 23:00, the patient experienced severe body aches, muscle and bones pain, fever, chills, dizziness, weakness, nausea, strong headache, painful and swollen lymph node on the arm the patient got the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events severe body aches, muscle and bones pain, fever, chills, dizziness, weakness, nausea, strong headache, painful and swollen lymph node on the arm the patient got the vaccine was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VENLAFAXINE; LAMOTRIGINE

Current Illness:

ID: 1792976
Sex: M
Age:
State: TX

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Stomach pain/diarrhea that started a few hours after injection and lasted about 24 hours; Stomach pain/diarrhea that started a few hours after injection and lasted about 24 hours; General sense of malaise for about 72 hours after shot; An extreme headache for about 24 hours which then turned into a mile headache for about 4 days; I developed tinnitus which has not gone away.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 09:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (ACETAMINOPHEN); both taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 13Mar2021 at 08:30 as a single dose for COVID-19 immunisation. On 01Apr2021, the patient experienced stomach pain/diarrhea that started a few hours after injection and lasted about 24 hours. General sense of malaise for about 72 hours after shot followed by an extreme headache for about 24 hours which then turned into a mild headache for about 4 days. On an unspecified date in Apr2021, when the headache turned milder, the patient developed tinnitus which has not gone away. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event stomach pain/diarrhea that started a few hours after injection and lasted about 24 hours was recovered on 02Apr2021. The clinical outcome of event general sense of malaise for about 72 hours after shot was recovered on 24Apr2021. The clinical outcome of the event an extreme headache for about 24 hours which then turned into a mild headache for about 4 days was not recovered at the time of the report. The clinical outcome of the event "I" developed tinnitus which has not gone away was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; ACETAMINOPHEN

Current Illness:

ID: 1792977
Sex: F
Age:
State: OH

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Chills; Headache; Fever; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 92-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 30Mar2021 at 11:30 (at the age of 92-years-old) as a single dose for COVID-19 immunisation. The medical history included A-Fib (Atrial fibrillation) and COVID-19. It was not sure whether the patient had any known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 31Mar2021, the patient experienced chills, headache, fever and extreme fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, headache, fever and extreme fatigue was recovered with sequelae on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1792978
Sex: F
Age:
State: CA

Vax Date: 04/12/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: extreme tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8279) via an unspecified route of administration in the arm left on 12Apr2021 at 13:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic asthma, hypertension, arthritis and tinnitus. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol tartrate (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) and famotidine (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication and unknown if ongoing. The patient previously received omeprazole sodium (MANUFACTURER UNKNOWN), midazolam (MANUFACTURER UNKNOWN), ketamine (MANUFACTURER UNKNOWN) and amoxicillin/clavulanic acid (MANUFACTURER UNKNOWN) and experienced drug allergy. On 15Apr2021 at 13:15, the patient experienced extreme tinnitus since vaccination, previously patient had a history of tinnitus that had been tolerable, but after vaccination it was extreme. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL TARTRATE; ASPIRIN [ACETYLSALICYLIC ACID]; FAMOTIDINE

Current Illness:

ID: 1792979
Sex: F
Age:
State: LA

Vax Date: 02/12/2021
Onset Date: 02/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Severe joint pain; This is a spontaneous report from a contactable healthcare professional, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 12Feb2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included spironolactone (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via an unspecified route of administration in the left arm on 22Jan2021 at 16:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 26Feb2021, the patient experienced severe joint pain. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe joint pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SPIRONOLACTONE

Current Illness:

ID: 1792980
Sex: F
Age:
State: SC

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Severe shoulder pain; Reduced mobility; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. On 09Apr2021, the patient experienced severe shoulder pain and reduced mobility. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe shoulder pain and reduced mobility were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1792981
Sex: F
Age:
State: PA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210415; Test Name: Body temmperature; Result Unstructured Data: Test Result:Fever over 100

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Severe chills; profuse sweating; stabbing joint pain; exhaustion; fever over 100; coughing; inability to sleep; body aches/over all body aches; mild headache; arm soreness; This is a spontaneous report from a contactable consumer (patient). A 52-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0164), via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 52-years-old) as dose 2, single for COVID-19 immunization. Medical history included high blood pressure, clinical depression, anxiety from an unknown date and unknown if ongoing. Patient had known allergies- Penicillin. Concomitant medication(s) included sertraline, venlafaxine hcl, lisinopril, hydrochlorothiazide taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: ER8733), via an unspecified route of administration in the left arm on 24Mar2021 at 14:00 (at the age of 52-years-old) as dose 1, single for COVID-19 immunization. The patient experienced body aches/overall body aches, mild headache, arm soreness on 14Apr2021 22:00 (At the rate 12 hours ) and severe chills, profuse sweating, stabbing joint pain, exhaustion, fever over 100, coughing, inability to sleep on 15Apr2021 (At the rate 24 hours). The patient underwent lab tests and procedures which included body temperature: fever over 100 on 15Apr2021. The patient did not receive any treatment for the events. The clinical outcome for the events was recovering. Follow-up attempts are completed. No further information is expected.

Other Meds: SERTRALINE; VENLAFAXINE HCL; LISINOPRIL; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1792982
Sex: F
Age:
State: IL

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Fatigue began 12 hours after injection and lasted for 48 hours; Sore deltoid 12 hours after injection and lasted for 24 hours.; Lethargy; Severe headache upon waking 2nd day after injection and lasted for 8 hours.; Fuzzy thinking for 2 days after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 10Apr2021 at 14:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included leaky gut, healthy otherwise and known allergies to penicillin, garlic and sulfur meds. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, 12 hours after the injection, the patient experienced fatigue and sore deltoid, second day after injection, experienced severe headache upon waking and also experienced lethargy and fuzzy thinking. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache was resolved on 11Apr2021, after a duration of 8 hours; pain in arm was resolved on 12Apr2021, after a duration of 24 hours; fatigue was resolved on 13Apr2021, after a duration of 48 hours; lethargy and fuzzy was resolved on 13Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1792983
Sex: M
Age:
State: WA

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: woke up with significant tinnitus in my right ear; woke up with tinnitus in right ear. Over the course of next day it went away from right but it still lingered overall and was aggravated. The days following, tinnitus settled back in left but is at the same aggravated levels it was back in 2014; the left ear feels stuffed up as do my sinuses; mild fatigue; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 07Apr2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included benign prostatic hyperplasia, mild tinnitus since 2014 and allergy to sulpha. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included silodosin (MANUFACTURER UNKNOWN) 8mg per day, for an unknown indication from an unknown date and unknown if ongoing. The patient previously received influenza vaccine (MANUFACTURER UNKNOWN) in the left arm on an unknown date for immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported that he had mild tinnitus in left ear since 2014. The onset of that had coincided with a flu shot he had taken then on the left arm. Since then, the tinnitus had subsided to a tolerable level. On 07Apr2021, the patient experienced mild fatigue. He was fine through the day. On 08Apr2021 at 03:00, that night the patient woke up with significant tinnitus in his right ear. Over the course of the next day, it went away from the right ear but it still lingered overall and was aggravated. The days following, the tinnitus settled back in the left ear but is at the same aggravated levels it was back in 2014 and also the patient experienced the left ear feels stuffed up as do his sinuses. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild fatigue, significant tinnitus in right ear. Over the course of the next day, it went away from the right ear but it still lingered overall and was aggravated. The days following, the tinnitus settled back in the left ear but is at the same aggravated levels it was back in 2014 and left ear feels stuffed up as do his sinuses was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SILODOSIN

Current Illness:

ID: 1792984
Sex: F
Age:
State:

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Diarrhea; Headache; Whole right arm sore; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 14Apr2021 at 14:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vortioxetine hydrobromide (TRINTELLIX), taken for an unspecified indication from an unknown date and unknown if ongoing. On 14Apr2021 at 14:15, the patient experienced diarrhea, headache, whole right arm sore and fatigue. The events did not result in doctor or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, headache, whole right arm sore and fatigue were not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: TRINTELLIX

Current Illness:

ID: 1792985
Sex: F
Age:
State:

Vax Date: 04/05/2021
Onset Date: 04/13/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Lymph node swelling; Severe rash inside mouth and throat; Severe rash inside mouth and throat; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to pollen. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included calcium carbonate (TUMS) for an unknown indication from an unknown date and unknown if ongoing. On 13Apr2021, the patient experienced lymph node swelling, severe rash inside mouth and throat that did not go away with unspecified allergy medicine, headache and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events lymph node swelling, headache and nausea. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lymph node swelling, severe rash inside mouth and throat, headache and nausea was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: TUMS [CALCIUM CARBONATE]

Current Illness:

ID: 1792986
Sex: F
Age:
State: NE

Vax Date: 04/08/2021
Onset Date: 04/10/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: 48 hours after my first dose, "I" had chills; Tiredness; Vomited; Fever; Joint pain; Extreme lower back pain; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 11:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included type II diabetes and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin glargine (LANTUS INSULIN) and dulaglutide (TRULICITY) both for an unknown indication from an unknown dates and unknown if ongoing. The patient previously took tetanus vaccine (MANUFACTURER UNKNOWN) and insulin lispro (HUMALOG) for an unknown indication from an unknown dates and experienced drug allergy. On 10Apr2021 at 12:00, 48 hours after her first dose, the patient experienced chills, tiredness, vomited, fever, joint pain and extreme lower back pain. The events did not result in doctor or other healthcare professional office or clinic, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, tiredness, vomited, fever, joint pain and extreme lower back pain were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LANTUS; TRULICITY

Current Illness:

ID: 1792987
Sex: M
Age:
State: DC

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Resting heart rate; Result Unstructured Data: Test Result:90 bpm; Comments: Doubled from normally 40 to nearly 90bpm; Test Date: 202104; Test Name: Resting heart rate; Result Unstructured Data: Test Result:40bpm; Test Date: 20210414; Test Name: SARS-CoV-2 test; Test Result: Negative

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Chills; Sweating; Body aches; Poking sensation in bicep away from where the shot was given; Headache; Shaking/jittery; Extreme tiredness; Dizziness; Resting heart rate doubled from normally 40 to nearly 90bpm; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 11:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy. It was reported that the patient was fairly healthy and the patient's family has history of heart issues. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluticasone propionate (FLONASE) for allergy from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 26Mar2021 at 11:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 00:00 the patient experienced chills; then followed by sweating; body aches; poking sensation in bicep away from where the shot was given, not near it; headache; shaking/jittery; extreme tiredness; dizziness and resting heart rate doubled from normally 40 to nearly 90bpm (beats per minute). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. On 14Apr2021, the patient underwent nasal swab test (SARS-CoV2-test) and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events chills; then followed by sweating; body aches; poking sensation in bicep away from where the shot was given, not near it; headache; shaking/jittery; extreme tiredness; dizziness and resting heart rate doubled from normally 40 to nearly 90bpm was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1792988
Sex: F
Age:
State: CA

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210409; Test Name: COVID test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: severe fatigue; chest pressure; shortness of breath/lose my breath; dizziness; They have continued for several weeks making it difficult for me to jog as I usually do. I lose my breath and feel like my heart is struggling.; They have continued for several weeks making it difficult for me to jog as I usually do. I lose my breath and feel like my heart is struggling.; This is a spontaneous report from a contactable other health care professional, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on the right arm on 20Mar2021 at 09:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic pain, fibromyalgia and migraines. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medication. The Patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 21Mar2021 at 17:00, approximately 30 hours after the shot, the patient experienced severe fatigue, chest pressure, shortness of breath and dizziness. It was reported that the patient had severe fatigue, chest pressure, shortness of breath and dizziness occurred. They had continued for several weeks and on unknown date in 2021, making it difficult for the patient to jog as she usually did and she lost her breath and felt like heart was struggling. On 09Apr2021, the patient underwent COVID test (nasal swab) and the result was negative. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events severe fatigue, chest pressure, shortness of breath, dizziness, had continued for several weeks making it difficult for her to jog as she usually did, lost her breath and felt like heart was struggling was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1792989
Sex: F
Age:
State: PA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Rash to shoulders, back, neck and face.; Facial spasms.; This is a spontaneous report from a contactable consumer. A 17-years-old Non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: ER8731), via an unspecified route of administration, administered in Arm Left on 16Apr2021 16:30 (Age at vaccination 17 Years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included current ankle FX, h/o tonsillitis with tonsillectomy and adenoidectomy, ear infections with myringotomy. Concomitant medication(s) included ethinylestradiol, ferrous fumarate, norethisterone acetate 1/20 (LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported; meloxicam (MOBIC) taken for an unspecified indication, start and stop date were not reported; diclofenac taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient was not tested for COVID-19. On 16Apr2021 18:45 the patient experienced rash to shoulders, back, neck and face, facial spasms. Patient visited Emergency room/department or urgent care. Therapeutic measures were taken as a result of events include Benedryl 50mg, Solumedrol 125mg IV. Reporter enquired about current guidance for administration of second dose after rash and facial tremors seen in a patient 2 hours post 1st dose. Outcome of events was recovered on unspecified date in 2021. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the event rash and facial spasm and the suspect drug BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: LOESTRIN FE; MOBIC; DICLOFENAC

Current Illness:

ID: 1792990
Sex: M
Age:
State: MI

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Initial soreness in right arm followed by joint aches throughout the body.; Initial soreness in right arm followed by joint aches throughout the body.; Next, persistent extreme fatigue that persists to today; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 12:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included morbid obesity, osteoarthritis, penicillin allergy, adhesives allergy (dermatitis contact), and lupus erythematosus (lupus). The patient had received medication which was not specified within two weeks of vaccination for unknown indication and unknown if ongoing. The patient previously took cefalexin (KEFLEX), clindamycin (CLEOCIN), vancomycin (MANUFACTURER UNKNOWN), levofloxacin (LEVOQUIN), clindamycin (MANUFACTURER UNKNOWN) and colchicine (MANUFACTURER UNKNOWN) and experienced drug allergy to these. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 22Mar2021 at 12:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 13:00, the patient experienced initial soreness in right arm followed by joint aches throughout the body. Next, persistent extreme fatigue that persisted to the day of report. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events initial soreness in right arm followed by joint aches throughout the body; next, persistent extreme fatigue that persisted to the day of report was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1792991
Sex: F
Age:
State: ME

Vax Date: 04/04/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Extreme muscle cramp in right calf; Extremely painful muscle; Can barely walk with it.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 04Apr2021 at 10:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN) for unknown indications from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on an unknown date Mar2021 at 10:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 11:00, the patient experienced extreme muscle cramp in right calf, first it was felt like a pop then it had been extremely painful and could barely walk with it. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme muscle cramp in right calf and extremely painful muscle and could barely walk was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SERTRALINE; BUPROPION

Current Illness:

ID: 1792992
Sex: F
Age:
State: NE

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Swollen lymph node behind shoulder on the same arm that received the injection 7 days after injection; Extreme fatigue 1 day after injection; Pain in same arm that received the injection 1 day after getting vaccination; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the right arm on 05Apr2021 at 16:45 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as N/A). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VITAMIN C) for an unknown indication from an unknown start date and unknown if ongoing. On 06Apr2021, the patient experienced extreme fatigue and pain in same arm 1 day after getting the vaccination. On 12Apr2021 at 06:00, the patient experienced swollen lymph node behind shoulder on the same arm that received the injection 7 days after injection. The event resulted in doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken as a result of the reported events and included treatment with hot compress, ibuprofen (MANUFACTURER UNKNOWN) and acetaminophen (MANUFACTURER UNKNOWN) from an unknown start date to an unknown stop date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, swollen lymph node behind shoulder and pain in arm were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1792993
Sex: M
Age:
State: IL

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Severe tinnitus; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 13Apr2021 at 10:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) for unknown an indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 13Apr2021 at 11:00, the patient experienced severe tinnitus 15 minutes after the second shot and also headaches. The events resulted in doctor or other healthcare professional office/clinic visit and also, emergency room/department visit or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events severe tinnitus and headaches was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1792994
Sex: F
Age:
State: TX

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Extremely exhausted; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 19:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to tuna (Fish allergy) and allergy to rosemary (herbal allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valaciclovir hydrochloride (VALACYCLOVIR), dicycloverine (DICYCLOMINE) and ascorbic acid (VITAMIN C) and multi-vitamins (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date and unknown if ongoing. On 16Apr2021 at 21:00, the patient was extremely exhausted and experienced nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely exhausted and nausea was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Valacyclovir [Valaciclovir Hydrochloride]; Dicyclomine; Vitamin C [Ascorbic Acid]

Current Illness:

ID: 1792995
Sex: F
Age:
State: KS

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: period started significantly earlier than it should have; previous period ended 4/5/21 my next one wasn't due to start until 5/6/21. I have a very regular menstrual cycle and do not experience spotting between cycles. I started bleeding again 4/15/21 5 hours after receiving the first dose of the vaccine; had worse cramps than I have ever had the entire time that I have been menstruating; This is a spontaneous report from a non-contactable consumer. A 28-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 15Apr2021 at 11:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and did not have any allergies to medications, food, or other products. It was unknown if the patient was pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 15Apr2021 at 16:30, the patient's period started significantly earlier than it should have. Previous period ended on 05Apr2021 and the next one was not due to start until 06May2021. The patient reported that she had a very regular menstrual cycle and do not experience spotting between cycles. It started bleeding again on 15Apr2021, 5 hours after receiving the first dose of the vaccine and also had worse cramps that she ever had the entire time she had been menstruating. The patient reported that if this continued through the weekend, she would make a doctors appointment. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events period started significantly earlier than it should have, started bleeding again 5 hours after receiving the first dose of the vaccine and the worse cramps that she ever had the entire time she had been menstruating was not recovered at this time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1792996
Sex: F
Age:
State: TN

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210330; Test Name: fever; Result Unstructured Data: Test Result:100.9 Fahrenheit

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: every joint in body hurt; felt nauseous from the pain; lower back started to ache; Second dose bled from injection and resulted in large bruise; Second dose bled from injection and resulted in large bruise; Woke up with mild headache; Had a mild fever (100.9 F); sleep was very broken with heavy sweat; sleep was very broken with heavy sweat; lethargic for the next 36 hours; This is a spontaneous report from a contactable consumer (patient herself). A 55-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EN6205; Expiration Date: 30Mar2021), dose 2 via an unspecified route of administration, administered in Arm Left on 29Mar2021 14:45 (Age at vaccination 55-years-old) as dose 2, single for covid-19 immunisation. The patient was not pregnant at time of vaccination. Medical history included thyroidism, allergies to medications, food, or other products: penicillin and some antibiotics, no food allergies from an unknown date and unknown if ongoing. Concomitant medications included zinc (ZINC), vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EN6208; Expiration Date was reported), dose 1 via intramuscular, administered in Arm Left on 08Mar2021 14:45 (Age at vaccination 55-years-old) as dose 1, single for covid-19 immunisation. The patient had experienced second dose bled from injection and resulted in large bruise. Woke up with mild headache, took Advil (200 mg), went to tennis match, at 11:00 am lower back started to ache. When back home at 12:00 pm every joint in body hurt, felt nauseous from the pain and had a headache. Had a mild fever (100.9 F), took Advil (2 times, 200 mg). Continued to medicate with Advil and Tylenol, as per instructions on the bottles, alternating for 12 hours to 12:00 am. During the night, sleep was very broken with heavy sweat. Woke up at 8:00 am feeling better since joint pain had subsided, but still had a mild headache which continued unmedicated as a dull headache and lethargic for the next 36 hours. The patient underwent lab tests and procedures which included body temperature: 100.9 Fahrenheit on 30Mar2021. The facility most recent COVID-19 vaccine administered was other. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received thyroid, zinc, vitamin D medications within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19 was none. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the events. Therapeutic measures were taken as a result of woke up with mild headache, had a mild fever (100.9 f). The clinical outcome of the events were recovered on 01Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ZINC; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1792997
Sex: M
Age:
State: TN

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Body temperature; Result Unstructured Data: Test Result:101

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: 101 Fever; Chills; Vomiting; Diarrhea; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 10:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 10:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 17:00, the patient experienced 101 fever, chills, vomiting, diarrhea and body aches. On the same day, the patient under went body temperature test and the result was found to be 101 (unspecified unit). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with TYLENOL. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 101 fever, chills, vomiting, diarrhea and body aches were not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1792998
Sex: U
Age:
State: WA

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210412; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Extreme weakness in right knee; It would not hold me and I was unable to walk on it. If I tried to walk, it would give out and I would almost fall; It would not hold me and I was unable to walk on it. If I tried to walk, it would give out and I would almost fall; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old patient of an unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 11Apr2021 at 14:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER6955) via an unspecified route of administration in the right arm on 21Mar2021 at 14:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 23:30, the patient experienced extreme weakness in right knee and it would not hold the patient and the patient was unable to walk on it and even if the patient tried to walk, it would gave out and the patient would almost fall. It lasted about 30-40 minutes and then went away. On 12Apr2021, the patient underwent nasal swab test and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events extreme weakness in right knee, unable to walk on it and tried to walk, it would gave out and would almost fall was recovered on 12Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1792999
Sex: M
Age:
State: TN

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Nausea; Headache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 29Mar2021 at 15:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included Factor V Leiden. The patient previously received fentanyl (MANUFACTURER UNKNOWN) on an unspecified date, for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included dabigatran etexilate mesilate (PRADAXA) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 19:00, the patient experienced nausea, headache and diarrhea. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea and headache were recovered on 31Mar2021, after the duration of 36 hours diarrhea was recovered on 02Apr2021, after the duration of 4 days. No follow-up attempts are needed. No further information is expected.

Other Meds: PRADAXA

Current Illness:

ID: 1793000
Sex: F
Age:
State: MD

Vax Date: 04/08/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210123; Test Name: COVID test; Test Result: Negative ; Comments: Nasal swab; Test Date: 20210110; Test Name: COVID test; Test Result: Negative ; Comments: Nasal swab; Test Date: 20210210; Test Name: COVID test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: the night of the 2nd day, and during the 3rd day I got vicious headaches; I had a heavy nosebleed which left me extremely exhausted for 2 days; I had a heavy nosebleed which left me extremely exhausted for 2 days; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 17:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included alopecia areata. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included malus spp. vinegar extract (APPLE CIDER VINEGAR) for unknown indication and ethinylestradiol/levonorgestrel (ALTAVERA) for birth control; both from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Jan2021, the patient underwent COVID test (Nasal swab) and the result was Negative. On 23Jan2021, the patient underwent COVID test (Nasal swab) and the result was Negative. On 10Feb2021, the patient underwent COVID test (Nasal swab) and the result was Negative. On 14Apr2021 at 07:15, the patient experienced heavy nosebleed which left the patient extremely exhausted for 2 days. On 16Apr2021, the night of the 2nd day, and during the 3rd day, the patient experienced vicious headaches and the 3rd day, the patient started feeling better. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely exhausted for 2 days was recovered on 16Apr2021 and of the events heavy nosebleed and vicious headaches was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: APPLE CIDER VINEGAR; ALTAVERA

Current Illness:

ID: 1793001
Sex: M
Age:
State: MA

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210407; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Vivid red itchy rash over whole body beginning on day 5 following injection. Has not gone away; Extreme fatigue; Low grade fevers; Chills; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amoxicillin (MANUFACTURER UNKNOWN); on an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 15:00 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 22:00, the patient experienced extreme fatigue, low grade fevers and chills. On 17Apr2021, day 5 following injection, the patient experienced vivid red itchy rash over whole body. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID. On 07Apr2021, the patient underwent Sars Cov-2 test (test type: Nasal Swab) and result was negative. The clinical outcome of the events extreme fatigue, low grade fevers, chills and vivid red itchy rash over whole body were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMOXICILLIN

Current Illness:

ID: 1793002
Sex: M
Age:
State: CO

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Ultrasound; Result Unstructured Data: Test Result:Hydrocele on right testicle.; Comments: Testicular ultrasound

Allergies:

Symptom List: Nausea

Symptoms: Developed a small hydrocele (smaller than a fingernail) on right testicle./ testicular ultrasound that showed the hydrocele on my right testicle.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 27Mar2021 at 09:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 27Mar2021 at 18:00, the patient developed a small hydrocele which was smaller than a fingernail on right testicle following the first dose of the vaccine. The patient experienced no other adverse effects. The symptoms lasted about 4 days and self-resolved. The events resulted in emergency room/department or urgent care. On an unknown date, the patient underwent ultrasound testes and the result was hydrocele on right testicle. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event small hydrocele on right testicle was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ESCITALOPRAM

Current Illness:

ID: 1793003
Sex: M
Age:
State: AR

Vax Date: 04/13/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: I got a large rash across most of my body.; Extremely itchy; This is a spontaneous report from a contactable consumer (patient). A 20-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 13Apr2021 17:45 (at the age of 20-year-old) (Lot Number: EW0151) as dose 1, single for COVID-19 immunization. Medical history included none. The patient did not have any known allergies. The patient's concomitant medication included Vita fusion MultiVites. The patient did not receive other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced a large rash across most of his body on 16Apr2021 08:00. The patient reported that it started in small spots and then quickly spread across his arms, stomach, back, and legs. It was extremely itchy but not painful. The patient required Doctor or other healthcare professional office/clinic visit. The patient received treatment with prednisone and fexofenadine (ALLEGRA). The outcome of events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1793004
Sex: M
Age:
State: IL

Vax Date: 04/06/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: "I" was very tired; Lethargic; Sleeping pretty much the whole day; Stomach cramping appeared; "I" woke up at 6am with significant chills; Severe abdominal pain; Brain fog; "I" started to experience back muscle cramping which progressed rapidly.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ENG6207) via an unspecified route of administration in the right arm on 06Apr2021 at 13:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 14Apr2021 at 06:00, in the morning the patient woke up with significant chills, severe abdominal pain and brain fog. On the same day around 11:15, the patient started to experience back muscle cramping which progressed rapidly and at 11:50, the patient was on a virtual meeting and was unable to sit up straight in a chair and had to end the meeting. These effects lasted for approximately 10 hours. On 15Apr2021 at 03:00 in the morning, the patient woke up with similar effects as the previous day but less pronounced. On the same day at 11:45 the chills, abdominal pain and brain fog subsided a bit. However, stomach cramping appeared. Then 9 hours after waking up all the effects were not evident. On 16Apr2021, the effects slowly dissipated but the patient was very tired, lethargic, sleeping pretty much the whole day. The event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events back muscle cramping, significant chills, severe abdominal pain, brain fog, stomach cramping, very tired, lethargic, sleeping pretty much the whole day were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793005
Sex: F
Age:
State: FL

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: painful swelling and feelings of numbness/tingling in both my hands/hands were swollen and hurting a lot; feelings of numbness/tingling in both my hands/numbing in her fingers and hands; feelings of numbness/tingling in both my hands, especially the right hand.; I also had some chest tightness/chest discomfort a little more in the report as heaviness; discomfort breathing; hard to breathe.; reddened hand; felt tired; This is a spontaneous report received from a contactable other hcp (patient) reporting for herself. A 53-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER8727, NDC number and Expiry date are unknown), via an unspecified route of administration, administered in Left arm on 27Mar2021 14:00 at the age of 53-years-old as dose 1, single for covid-19 immunisation. Medical history included asthma from an unknown date. Other conditions were not provided. The patient's concomitant medications were not reported. The patient previously took sulfa and experienced allergy. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. Investigations were not provided. On 07Apr2021, the patient woke up around 2:30 AM with painful swelling and feelings of numbness/tingling in both her hands, especially the right hand. She was given the vaccine in her left arm. She also had some chest tightness and discomfort breathing. Most of the symptoms subsided within a few days, except for the numbness/tingling that lessened but are ongoing issues. The reporter wanted to speak regarding side effects after receiving the first dose of the Pfizer covid vaccine on 27Mar2021. On 06Apr2021 she woke up at 2:30 AM with reddened hand and numbness to hand, additionally she woke up with chest tightness. She asked, should she take the second dose since she had this reaction? If she does take the second dose and the reaction is worse, what does she do? The patient had the first shot on 27Mar2021 and is scheduled take second one Friday. Stated that she felt tired next day on 28Mar2021 and was fine. Stated on 06 or 07 Apr that she woke up and her hands were swollen and hurting a lot. Stated that that for the next few days someone that it felt like someone was sitting on her chest and discomfort. Stated that most of it went away. Stated that she had numbing in her fingers and hands. Wanted to know if these are expected side effects should she get vaccine that would go away or if she should be cautious. Wanted to know for the chest discomfort is there anything to take that would not interfere with the vaccine. It was stated that she reported all of the above except she phrased chest discomfort a little more in the report as heaviness/hard to breathe on 07Apr2021 at 02:30. No treatment was received for the adverse events. Adverse events resulted in none of the above. The outcome of events was recovered with sequelae. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793006
Sex: F
Age:
State: KY

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Headache; Sore arm; Enlarged lymph node (left armpit); Lethargy; Intense pain in thighs; Hot to touch thighs; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 13Apr2021 at 09:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration on 23Mar2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. On 14Apr2021, the patient experienced headache, sore arm, enlarged lymph node (left armpit), lethargy, intense pain or hot to touch thighs. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, sore arm, enlarged lymph node (left armpit), lethargy, intense pain or hot to touch thighs was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793007
Sex: F
Age:
State: IN

Vax Date: 04/13/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Started having period, haven't had a period in over a year. Horrible cramps, migraine also. Started 3 days after shot.; Started having period haven't had a period in over a year. Horrible cramps; Horrible cramps, migraine also.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the arm right on 13Apr2021 at 14:00(at the age of 46-years-old) as a single dose for COVID-19 immunisation. The medical history included blood pressure high, migraines, contraceptive implants and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications of blood pressure, migraine and implant for birth control. On 16Apr2021 at 17:00, 3 days after shot, the patient started having period, horrible cramps and migraine also. The patient reported that she had not have a period in over a year. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events started having period, horrible cramps and migraine was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793008
Sex: F
Age:
State: FL

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Menstruation was much much heavierthan normal; Menstrual lasted a total of seven (7) days compared to the usual four (4) days; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 16:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 21:00, the patient menstruation period began the day that she took the shot (as per her usual cycle), but it was much much heavier than normal and lasted a total of seven (7) days compared to the usual four (4) days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events menstruation was much much heavier than normal and lasted a total of seven (7) days compared to the usual four (4) days was recovered on 16Apr2021, after the duration of 7 days.. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793009
Sex: F
Age:
State: GA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210415; Test Name: Body temperature; Result Unstructured Data: Test Result:103.8; Comments: fever as high as 103.8

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: a rash that felt like the injection site was on fire; a rash that felt like the injection site was on fire; chills; headache; extreme fatigue; Low grade fever/ fever as high as 103.8; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 15:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and psoriatic arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and vitamin d nos (MANUFACTURER UNKNOWN), both for an unknown indication from an unknown date and unknown if ongoing. The patient previously took doxycycline (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 14Apr2021 at 18:30, the patient experienced low grade fever within 3 hours of second shot. On 15Apr2021, second day, the patient experienced fever as high as 103.8 (unspecified units), chills, headache and extreme fatigue. On 16Apr2021, third day, experienced low grade fever and a rash that felt like the injection site was on fire. On 15Apr2021, the patient underwent body temperature test and the result was as high as 103.8 (unspecified units). The events resulted in a visit to the emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with Ibuprofen (MANUFACTURER UNKNOWN) and anti-nausea medication (unspecified) and diphenhydramine hydrochloride (BENADRYL) cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade fever, fever as high as 103.8, chills ,headache, extreme fatigue, rash that felt like the injection site was on fire was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VITAMIN D NOS

Current Illness:

ID: 1793010
Sex: F
Age:
State: NC

Vax Date: 04/15/2021
Onset Date: 04/17/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Hot flash; Dizziness; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 15Apr2021 at 13:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. It was unknown, if the patient was pregnant at the time of this report. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included vitamins (unspecified) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 18:15, 2 days after vaccination, the patient experienced hot flash, dizziness and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hot flash, dizziness and diarrhea was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793011
Sex: F
Age:
State: MI

Vax Date: 04/08/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210414; Test Name: COVID Rapid Test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: A wave of dizziness; Burning sensations all through my body; Tingling pins and needles feeling; Numbness; Severe weakness; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 08Apr2021 at 12:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included Bi-lateral cochlear implants and congenital deafness. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included pseudoephedrine hydrochloride (SUDAFED), taken for an unknown indication from an unknown date and unknown if ongoing. On 14Apr2021 at 19:45, 6 days after the vaccination, the patient experienced a wave of dizziness, had burning sensations all through her body, tingling pins and needles feeling, with numbness and severe weakness. The patient felt like a wave that overtook from head to feet which required her to call 911 with an ambulance ride to the Emergency Room (ER) and after ruling out several things, the patient believed that it might be a side effect from the vaccine and still had lingering side effects 3 days after visit from ER. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 14Apr2021, the patient underwent COVID-19 rapid test (nasal swab) and the result was negative. The clinical outcome of the events dizziness, burning sensations all through body, tingling pins and needles feeling, numbness and severe weakness were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]

Current Illness:

ID: 1793012
Sex: F
Age:
State: MA

Vax Date: 03/01/2021
Onset Date: 04/09/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Diarrhea; Arm aching; Chills; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Mar2021 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. On 09Apr2021 at 12:30, the patient experienced diarrhea which started 1 week after receiving first shot, arm aching for 2 days and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm aching was recovered on 11Apr2021, after 2 days and the outcome of the events diarrhea and chills was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793013
Sex: M
Age:
State: NY

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210415; Test Name: PCR; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Pain in extremity

Symptoms: Pain in both my thumbs; Mild nausea; Runny nose; Extreme tiredness; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8739) via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin sulfa and hops. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 15Apr2021 at 15:00, the patient experienced pain in both thumbs, mild nausea, runny nose and extreme tiredness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken for the reported events. Since the vaccination, the patient had been tested for COVID-19. On 15Apr2021, the patient underwent PCR test (Nasal Swab: test type) and the result was found to be negative. The clinical outcome of the events pain in both thumbs, mild nausea, runny nose and extreme tiredness were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793014
Sex: F
Age:
State: PA

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 32-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Apr2021 at 15:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medication within two weeks of vaccination. On 17Apr2021 at 20:30, the patient experienced headache, nausea, stomach cramping, diarrhea, weakness, easily fatigued and tired. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, stomach cramping, diarrhea, weakness, easily fatigued and tired was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793015
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Sore arm; Extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 2, anxiety, high blood pressure and high cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included insulin glargine (LANTUS) (reported as Lantus Solostar), glipizide (MANUFACTURER UNKNOWN), Centrum Silver and lysine (MANUFACTURER UNKNOWN) all taken for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 12:00, the patient experienced sore arm and felt extremely tired. Therapeutic measures were taken as a result of the events and included treatment with acetaminophen (MANUFACTURER UNKNOWN) and sleep. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm and extremely tired was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LANTUS; GLIPIZIDE; LYSINE

Current Illness:

ID: 1793016
Sex: F
Age:
State: IN

Vax Date: 04/14/2021
Onset Date: 04/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: Body temperature; Result Unstructured Data: Test Result:102; Comments: Fever 102

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Fever 102; Chills; Extreme weakness; Horrible headache; Sick to stomach; This is a spontaneous report from a contactable consumer, the patient. A 88-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 13:15 (at the age of 88-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to penicillin and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. On an unknown date in Apr2021, the patient experienced fever 102, chills, extreme weakness, horrible headache, sick to her stomach. On an unknown date in Apr2021, the patient underwent body temperature test and the result was found to be 102 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever 102, chills, extreme weakness, horrible headache, sick to her stomach was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793017
Sex: M
Age:
State: FL

Vax Date: 04/04/2021
Onset Date: 04/06/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Conjunctivitis in right eye; Conjunctivitis in right eye. Prolonger swelling; Conjunctivitis in right eye. Prolonger swelling, redness; Conjunctivitis in right eye. Prolonger swelling, redness, itching; Tearing; Sensitivity; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 04Apr2021 at 11:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination and did not receive any concomitant medications within two weeks of vaccination. On 06Apr2021 at 20:00, the patient experienced conjunctivitis in right eye, prolonger swelling, redness, itching, tearing and sensitivity. The patient reported that currently 7plus days, slowly improving and has not seen a doctor. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events conjunctivitis in right eye, prolonger swelling, redness, itching, tearing and sensitivity was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793018
Sex: F
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Rash all over body (arms, legs, back, buttocks area); This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWOIS 1) via an unspecified route of administration in the left arm on 15Apr2021 at 12:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sulfamethoxazole, trimethoprim (SULFAMETH/TRIMETH), taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EPG955) via an unspecified route of administration in the left arm on18Mar2021 at 12:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 08:00, the patient experienced rash all over body (arms, legs, back, buttocks area). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash all over body (arms, legs, back, buttocks area) was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SULFAMETH/TRIMETH

Current Illness:

ID: 1793019
Sex: F
Age:
State: NJ

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Fever; Chills; Body aches; Headache; Sore arm where injection was; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 15:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and anxiety. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included citalopram (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN) for unknown indications, from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 15:45 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 04:30, the patient experienced fever, chills, body aches, headache, sore arm where injection was and fatigue, lasted a little over 24 hours except for headache which lasted more like 36 hours or so. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, body aches, headache, sore arm where injection was and fatigue was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: CITALOPRAM; LISINOPRIL; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1793020
Sex: F
Age:
State: AZ

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Fever; Chills; Sore throat; Headache; Body ache; Stomach ache; This is a spontaneous report from a contactable consumer, the patient, A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 06:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 11:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. On 16Apr2021 at 15:00, the patient experienced fever, chills, sore throat, headache, body ache and stomach ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, sore throat, headache, body ache and stomach ache was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1793021
Sex: F
Age:
State: AZ

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Fever; Headache; Chills; Chest pain; Muscle pain; Site injection pain; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 17Apr2021 at 09:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to vaccination, the patient was diagnosed with COVID-19). The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 27Mar2021 at 16:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 21:00, the patient experienced fever, headache, chills, chest pain, muscle pain and site injection pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of fever, headache, chills, chest pain, muscle pain and site injection pain was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793022
Sex: M
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Chills/ Chattering teeth; Severe vertigo; Nausea; loose bowels; Profuse sweating; Lethargy; Headache; Joint pain; General disorientation; Slept 16 straight hours; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0160) via an unspecified route of administration in the left arm on 14Apr2021 at 12:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not have relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included carbidopa, levodopa (MANUFACTURER UNKNOWN) and rasagiline mesylate (MANUFACTURER UNKNOWN) from an unknown date, for unknown indication and unknown if ongoing. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 at 12:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 23:00, the patient experienced chills/ chattering teeth, severe vertigo, nausea, loose bowels, profuse sweating, lethargy, headache, joint pain, general disorientation, slept 16 straight hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills/ chattering teeth, severe vertigo, nausea, loose bowels, profuse sweating, lethargy, headache, Joint pain, general disorientation, slept 16 straight hours was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CARBIDOPA LEVODOPA; RASAGILINE MESYLATE

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am